Company Cell MedX Corp. Other OTC
Equities
CMXC
US15115X1072
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Monthly Subscriptions
58.8
%
| 0 | 60.6 % | 0 | 58.8 % | -55.85% |
eBalance Devices
41.2
%
| 0 | 39.4 % | 0 | 41.2 % | -52.33% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -54.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12-11 |
Yanika Silina
DFI | Director of Finance/CFO | 46 | 14-11-23 |
George Adams
CHM | Chairman | 76 | 18-03-22 |
Joao da Costa
BRD | Director/Board Member | 59 | 20-06-07 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 22-04-26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12-11 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 22-04-26 |
Joao da Costa
BRD | Director/Board Member | 59 | 20-06-07 |
George Adams
CHM | Chairman | 76 | 18-03-22 |
Amir Vahabzadeh
BRD | Director/Board Member | 55 | 12-11 |
Yanika Silina
DFI | Director of Finance/CFO | 46 | 14-11-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 297,236,373 | 60,447,694 ( 20.34 %) | 0 | 20.34 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |